C.s. Farmacos Drogas de Alto Costo
Las presentes bases enmarcan los requerimientos de la Unidad de Farmacia del Hospital La Serena bajo la licitación “C.S. Fármacos drogas de alto costo”, ID 1057439-74-LR21 con el fin de obtener el suministro de los fármacos y otros requerimientos señalados en punto B de las presentes bases de licitación, los cuales son necesarios para la adecuada y oportuna atención de todos los pacientes del Hospital de La Serena, tanto en Atención Abierta como en la Atención Cerrada
14 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058043-425-SE25 | 25-02-2025 | Galenicum Health Chile SpA | $5.340.863 |
| 1058043-406-SE25 | 21-02-2025 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $48.503.876 |
| 1058043-15-SE25 | 03-01-2025 | Galenicum Health Chile SpA | $7.121.150 |
| 1058043-13-SE25 | 03-01-2025 | Bayer S.A. | $20.068.769 |
| 1058043-1861-SE24 | 16-12-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $83.871.286 |
| 1058043-1855-SE24 | 20-11-2024 | Productos Farmoquimicos Roche Limitada | $17.706.498 |
| 1058043-1835-SE24 | 20-11-2024 | Galenicum Health Chile SpA | $5.340.863 |
| 1058043-1590-SE24 | 10-10-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $44.663.994 |
| 1058043-1634-SE24 | 04-10-2024 | Galenicum Health Chile SpA | $5.340.863 |
| 1058043-1622-SE24 | 02-10-2024 | Productos Farmoquimicos Roche Limitada | $42.495.595 |
| 1058043-1239-SE24 | 13-08-2024 | Productos Farmoquimicos Roche Limitada | $7.082.599 |
| 1058043-1240-SE24 | 13-08-2024 | Synthon Chile Limitada | $7.996.800 |
| 1058043-1225-SE24 | 08-08-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $12.125.969 |
| 1058043-1230-SE24 | 08-08-2024 | Dr. Reddys Laboratories Chile SpA | $3.561.075 |
| 1058043-1228-SE24 | 08-08-2024 | Productos Farmoquimicos Roche Limitada | $24.789.097 |
| 1058043-1004-SE24 | 03-07-2024 | Galenicum Health Chile SpA | $5.340.863 |
| 1058043-1015-SE24 | 02-07-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $29.304.428 |
| 1058043-855-SE24 | 06-06-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $67.097.017 |
| 1058043-853-SE24 | 04-06-2024 | Synthon Chile Limitada | $4.998.000 |
| 1058043-854-SE24 | 04-06-2024 | Productos Farmoquimicos Roche Limitada | $35.412.996 |
| 1058043-674-SE24 | 24-04-2024 | Bayer S.A. | $36.792.744 |
| 1058043-647-SE24 | 22-04-2024 | Productos Farmoquimicos Roche Limitada | $21.247.797 |
| 1058043-641-SE24 | 22-04-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $21.624.649 |
| 1058043-576-SE24 | 15-04-2024 | Synthon Chile Limitada | $5.747.700 |
| 1058043-506-SE24 | 21-03-2024 | Productos Farmoquimicos Roche Limitada | $17.706.498 |
| 1058043-360-SE24 | 27-02-2024 | Bayer S.A. | $26.758.359 |
| 1058043-335-SE24 | 22-02-2024 | Synthon Chile Limitada | $2.748.900 |
| 1058043-333-SE24 | 22-02-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $43.653.489 |
| 1058043-107-SE24 | 16-01-2024 | Bayer S.A. | $11.945.696 |
| 1058043-106-SE24 | 16-01-2024 | Dr. Reddys Laboratories Chile SpA | $3.798.480 |
| 1058043-1963-SE23 | 02-01-2024 | Productos Farmoquimicos Roche Limitada | $33.642.346 |
| 1058043-1961-SE23 | 02-01-2024 | Pfizer Chile S.A. | $17.501.854 |
| 1058043-1960-SE23 | 02-01-2024 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $30.112.831 |
| 1058043-1970-SE23 | 02-01-2024 | Bayer S.A. | $10.034.385 |
| 1058043-1962-SE23 | 02-01-2024 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $122.966.637 |
| 1058043-1956-SE23 | 26-12-2023 | Synthon Chile Limitada | $4.498.200 |
| 1058043-1694-SE23 | 15-11-2023 | Dr. Reddys Laboratories Chile SpA | $5.878.600 |
| 1058043-1617-SE23 | 24-10-2023 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $106.413.435 |
| 1058043-1614-SE23 | 23-10-2023 | Bayer S.A. | $30.103.154 |
| 1058043-1604-SE23 | 23-10-2023 | Synthon Chile Limitada | $2.249.100 |
| 1058043-1607-SE23 | 23-10-2023 | Pfizer Chile S.A. | $5.833.951 |
| 1058043-1274-SE23 | 21-08-2023 | Bayer S.A. | $16.723.974 |
| 1058043-1257-SE23 | 18-08-2023 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $48.503.876 |
| 1058043-1199-SE23 | 11-08-2023 | Synthon Chile Limitada | $1.632.680 |
| 1058043-1080-SE23 | 25-07-2023 | Synthon Chile Limitada | $1.499.400 |
| 1058043-1073-SE23 | 24-07-2023 | Dr. Reddys Laboratories Chile SpA | $3.391.500 |
| 1058043-1074-SE23 | 24-07-2023 | Productos Farmoquimicos Roche Limitada | $8.853.249 |
| 1058043-1050-SE23 | 21-07-2023 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $31.325.439 |
| 1058043-1032-SE23 | 20-07-2023 | Bayer S.A. | $31.476.909 |
| 1058043-962-SE23 | 06-07-2023 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $17.178.438 |
| 1058043-793-SE23 | 05-06-2023 | Dr. Reddys Laboratories Chile SpA | $4.522.000 |
| 1058043-702-SE23 | 26-05-2023 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | $67.703.325 |
Fuente original:ficha mercadopublico.cl
